Recipharm Completes Kemwell Acquisition
PTSM: Pharmaceutical Technology Sourcing and Management
Recipharm’s addition of Kemwell’s Bengaluru, India facility expands its solid- and liquid-dosage capabilities.
Recipharm announced on Feb. 20, 2017 that it completed the acquisition of Kemwell’s pharmaceutical businesses located in Bengaluru, India. The acquisition extends Recipharm’s capabilities in India.
As part of the transaction, Recipharm also has a right of first negotiation to acquire Kemwell’s Indian biopharma business, which is not included in the transaction and will continue to be retained by the sellers.
The acquired business, Recipharm Pharmaservices Private Ltd, employs 1200 and offers development services and commercial manufacturing of solid, semi-solid, liquid, and topical products. The solid-dosage plant was commissioned in 2008 and has approvals from US FDA, European Union, and other regulatory bodies. The oral liquids production plant was commissioned in 2011 and features automated high throughput large volume manufacturing, mainly for the Indian subcontinent. The development business provides formulation development, small-scale manufacturing for clinical trials and analytical services.
The acquisition was announced in April 2016.
Source: Recipharm
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
